HUNTERTUTORING

Medicinal chemistry

Graduate · Chemistry

Syllabus focus

Standard syllabus · STEM / applied

Pricing

Graduate-level rates are set on consultation. See the pricing page for K–12 and undergraduate rates.

Topics typically covered

Standard syllabus

Drug design principles

  • Structure-based drug design (SBDD) workflow
  • Ligand-based drug design and pharmacophore modeling
  • Fragment-based drug discovery (FBDD)
  • Bioisosteres and scaffold hopping
  • Privileged structures and drug-like scaffolds
  • Conformational restriction and preorganization
  • Prodrug design and targeted delivery strategies
  • Salt and polymorph selection for development
  • Intellectual property strategy in medicinal chemistry
  • Target validation and druggability assessment

ADMET optimization

  • Lipophilicity, solubility, and permeability balance
  • Caco-2 and PAMPA permeability models
  • Blood-brain barrier penetration prediction
  • Cytochrome P450 inhibition and induction
  • Reactive metabolites and bioactivation toxicity
  • hERG channel liability and cardiac safety
  • Plasma protein binding and free drug hypothesis
  • Metabolic stability assays: microsomal, hepatocyte
  • PK/PD modeling for dose selection (introduction)
  • Formulation chemistry for oral, IV, and topical delivery

Synthetic medicinal chemistry

  • Scale-up considerations for drug candidates
  • Process route scouting and patent avoidance
  • Asymmetric synthesis for enantiopure drugs
  • Late-stage functionalization in drug optimization
  • Parallel synthesis and SAR library generation
  • High-throughput chemistry and automation
  • Green chemistry metrics in pharmaceutical manufacturing
  • Impurity profiling and specification setting
  • Solid-form screening: salts, cocrystals, amorphous dispersions
  • GMP synthesis and regulatory chemistry requirements

Therapeutic areas and case studies

  • Oncology: kinase inhibitors, immunotherapies, ADCs
  • CNS drugs: blood-brain barrier, receptor selectivity
  • Antibiotics and antimicrobial resistance
  • Antiviral drug design: protease and polymerase inhibitors
  • Cardiovascular and metabolic disease targets
  • Anti-inflammatory and immunomodulatory drugs
  • Rare disease and orphan drug programs
  • Biologics vs small molecules: decision frameworks
  • Failed drugs and lessons from clinical setbacks
  • FDA approval pathways: NDA, ANDA, BLA (overview)

STEM / applied

Research and industry skills

  • Molecular docking and scoring in drug design projects
  • Medicinal chemistry notebook and electronic lab records
  • SAR table management and data visualization
  • In vitro assay interpretation and data quality assessment
  • Patent searching and freedom-to-operate analysis
  • Cross-functional collaboration with biology and DMPK teams
  • IND-enabling studies chemistry support
  • Manufacturing technology transfer
  • Regulatory submission document preparation (CMC sections)
  • Interview preparation for medicinal chemistry positions

Applied medicinal chemistry

  • Big pharma vs biotech career trajectories
  • Contract research organizations (CROs) and CDMOs
  • AI/ML in drug discovery: generative chemistry
  • Deliberate drug design failures and attrition analysis
  • Repurposing and reformulation strategies
  • Global health and neglected disease drug development
  • Controlled substance chemistry and DEA regulations
  • Pharmacovigilance and post-market surveillance chemistry
  • Biosimilars and generic drug chemistry
  • Entrepreneurship in drug discovery startups

Notes

Graduate-level medicinal chemistry. Topics reflect common medicinal chemistry syllabi at US research universities and pharmacy schools. Prior organic chemistry and introductory medicinal chemistry expected.